Physician profile
Yin Wang
NPI 1639764624
$2,303.09
in general payments reported to CMS, 2019-2025
17 companies · $861 in 2025
The $861 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $405 · 2023: $827 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,687.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $455.89 | 2022-2023 | Onpattro, Amvuttra |
| Novartis Pharmaceuticals Corporation | $337.02 | 2021-2023 | Leqvio |
| Boston Scientific Corporation | $285.03 | 2025 | Ams 700, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $249.98 | 2021-2023 | Farxiga |
| Janssen Pharmaceuticals, INC | $151.07 | 2023 | Xarelto |
| Acadia Pharmaceuticals INC | $122.17 | 2025 | Daybue |
| Kyowa Kirin, INC. | $120.56 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $114.15 | 2025 | Austedo Xr |
| Amarin Pharma, INC. | $112.65 | 2025 | Vascepa |
| Abiomed | $105.96 | 2025 | |
| Philips North America LLC | $103.01 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $63.80 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $23.48 | 2023 | Optimizer |
| Medicomp INC | $18.71 | 2023 | Telepatch Cardiac Monitor |
| Kiniksa Pharmaceuticals, LTD. | $13.64 | 2023 | Arcalyst |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $13.52 | 2021 | |
| Pfizer INC. | $12.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yin Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.